Makhdum Ahmed

ORCID: 0000-0002-0772-8710
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • CAR-T cell therapy research
  • Influenza Virus Research Studies
  • Respiratory viral infections research
  • Monoclonal and Polyclonal Antibodies Research
  • COVID-19 epidemiological studies
  • Viral gastroenteritis research and epidemiology
  • Cutaneous lymphoproliferative disorders research
  • Radiopharmaceutical Chemistry and Applications
  • Biochemical and Molecular Research
  • Ubiquitin and proteasome pathways
  • Pneumonia and Respiratory Infections
  • Galectins and Cancer Biology
  • PI3K/AKT/mTOR signaling in cancer
  • Cancer Genomics and Diagnostics
  • Viral-associated cancers and disorders
  • Viral Infections and Outbreaks Research
  • Vaccine Coverage and Hesitancy
  • Acute Lymphoblastic Leukemia research
  • RNA modifications and cancer
  • Gastrointestinal Tumor Research and Treatment
  • Child Nutrition and Water Access
  • Genetic factors in colorectal cancer
  • Immunodeficiency and Autoimmune Disorders

The University of Sydney
2025

AstraZeneca (United States)
2024

Southampton General Hospital
2024

AstraZeneca (Brazil)
2024

Sanofi (United States)
2019-2022

International Centre for Diarrhoeal Disease Research
1983-2020

The University of Texas MD Anderson Cancer Center
1998-2019

Lymphoma Research Foundation
2018

The University of Texas Health Science Center at Houston
2016-2017

Office of Infectious Diseases
2017

A. Danielle Iuliano Katherine Roguski Howard H. Chang David Muscatello Rakhee Palekar and 95 more Stefano Tempia Cheryl Cohen Jon Michael Gran Dena L. Schanzer Benjamin J. Cowling Peng Wu Jan Kynčl Li Wei Ang Minah Park Monika Redlberger‐Fritz Hongjie Yu Laura Espenhain Anand Krishnan Gideon O. Emukule Liselotte van Asten Susana Pereira Silva Suchunya Aungkulanon Udo Buchholz Marc‐Alain Widdowson Joseph Bresee Eduardo Azziz‐Baumgartner Po‐Yung Cheng Fatimah S. Dawood Ivo Foppa Sonja J. Olsen Michael Haber Caprichia Jeffers C. Raina MacIntyre Anthony T. Newall James G. Wood Michael Kundi Therese Popow‐Kraupp Makhdum Ahmed Mahmudur Rahman Maria de Fátima Marinho de Souza C Viviana Sotomayor Proschle Natalia Vergara Mallegas Shuo Feng Sa Li Juliana Barbosa-Ramírez Diana Malo Sanchez Leandra Abarca Gómez Xiomara Badilla Vargas aBetsy Acosta Herrera María Josefa Llanés Thea Kølsen Fischer Tyra Grove Krause Kåre Mølbak Jens Nielsen Ramona Trebbien Alfredo Bruno Jenny Ojeda Héctor Romero Ramos Matthias an der Heiden Leticia del Carmen Castillo Signor Carlos Enrique Lemus Serrano Rohit Bhardwaj Mandeep Chadha Venkatesh Vinayak Narayan Soewarta Kosen Michal Bromberg Aharona Glatman‐Freedman Zalman Kaufman Yuzo Arima Kazunori Oishi Sandra S. Chaves Bryan O. Nyawanda Reem Abdullah Al-Jarallah Pablo Kuri‐Morales Cuitláhuac Ruiz Matus María Eugenia Jiménez Corona Burmaa Alexander Oyungerel Darmaa Majdouline Obtel Imad Cherkaoui Cees C. van den Wijngaard Wim van der Hoek Michael G. Baker Don Bandaranayake Ange Bissielo Q. Sue Huang Liza Lopez E. Claire Newbern Elmira Flem Gry Marysol Grøneng Siri Helene Hauge Federico G. de Cosío Yadira Moltó Lourdes Moreno Castillo María Águeda Cabello Marta Von Horoch José Medina Ausenda Machado Baltazar Nunes Ana Paula Rodrigues

10.1016/s0140-6736(17)33293-2 article EN The Lancet 2017-12-14

Metabolic reprogramming is linked to cancer cell growth and proliferation, metastasis, therapeutic resistance in a multitude of cancers. Targeting dysregulated metabolic pathways overcome resistance, an urgent clinical need all relapsed/refractory cancers, remains difficult. Through genomic analyses specimens, we show that toward oxidative phosphorylation (OXPHOS) glutaminolysis associated with the Bruton's tyrosine kinase inhibitor ibrutinib mantle lymphoma (MCL), B subtype poor outcomes....

10.1126/scitranslmed.aau1167 article EN Science Translational Medicine 2019-05-08

Summary Long term outcomes and mutations in patients with mantle cell lymphoma (MCL) who discontinued ibrutinib have not been described. Using deep targeted next generation sequencing, we performed somatic mutation profiling from 15 MCL (including 5 paired samples; before after progression on ibrutinib). We identified 80 therapy for various reasons. Median follow‐up discontinuation was 38 months. The median duration 7·6 Forty‐one (51%) due to disease progression/transformation, 20 (25%)...

10.1111/bjh.15567 article EN British Journal of Haematology 2018-09-02

Abstract Purpose: Patients with B-cell lymphomas often relapse after frontline therapy, and novel therapies are urgently needed to provide long-term remission. We established lymphoma patient-derived xenograft (PDX) models assess their ability mimic tumor biology identify patient treatment options. Experimental Design: the PDX from 16 patients diffuse large lymphoma, mantle cell follicular marginal zone or Burkitt by inoculating cells into a human bone chip implanted mice. subjected...

10.1158/1078-0432.ccr-16-2703 article EN Clinical Cancer Research 2017-03-28

Rationale There is little evidence for the efficacy of handwashing prevention influenza transmission in resource-poor settings. We tested impact intensive promotion on household influenza-like illness and rural Bangladesh. Methods In 2009–10, we identified index case-patients with (fever cough or sore throat) who were only symptomatic person their household. Household compounds randomized to control intervention (soap daily promotion). conducted surveillance collected oropharyngeal...

10.1371/journal.pone.0125200 article EN public-domain PLoS ONE 2015-06-11

Inappropriate dispensing of antibiotics for acute respiratory illness (ARI) is common among drug sellers in Bangladesh. In this study, we evaluated the impact an educational intervention to promote guidelines better ARI management sellers. From June 2012 December 2013, conducted baseline and post-intervention surveys on practices 100 pharmacies within Dhaka city. these surveys, participated 6 standardized role-playing scenarios led by study staffs acting as caregivers patients were blinded...

10.1186/s12913-018-3486-y article EN cc-by BMC Health Services Research 2018-08-31

Schoolchildren are commonly linked to influenza transmission. Handwashing with soap has been shown decrease infections; however, improving handwashing practices using and water is difficult in low-resource settings. In these settings, alternative hygiene options, such as hand sanitizer, could improve promotion reduce virus infections. We conducted a cluster randomized control trial 24 primary schools Dhaka assess the effectiveness of sanitizer respiratory education intervention reducing...

10.4269/ajtmh.19-0376 article EN American Journal of Tropical Medicine and Hygiene 2019-11-04

Background Seasonal influenza‐associated mortality estimates help identify the burden of disease and assess value public health interventions such as annual influenza immunization. Vital registration is limited in Bangladesh making it difficult to estimate seasonal mortality. Objectives Our study aimed rates for 2010‐2012 Bangladesh. Methods We conducted surveillance among hospitalized patients with severe acute respiratory illness ( SARI ) persons aged ≥5 years pneumonia children <5 11...

10.1111/irv.12490 article EN cc-by Influenza and Other Respiratory Viruses 2017-12-02

The International Health Regulations outline core requirements to ensure the detection of public health threats international concern. Assessing capacity surveillance systems detect these is crucial for evaluating a country's ability meet requirements.We propose framework evaluate sensitivity and representativeness hospital-based apply it severe neurological infectious diseases fatal respiratory in Bangladesh. We identified cases selected communities within hospital catchment areas using key...

10.1371/journal.pmed.1002218 article EN public-domain PLoS Medicine 2017-01-17

We combined hospital-based surveillance and health utilization survey data to estimate the incidence of respiratory viral infections associated hospitalization among children aged < 5 years in Bangladesh.

10.1371/journal.pone.0147982 article EN public-domain PLoS ONE 2016-02-03

Background: Pharmacies in Bangladesh serve as an important source of health service. A survey Dhaka reported that 48% respondents with symptoms acute respiratory illness (ARI) identified local pharmacies their first point care. This study explores the factors driving urban customers to seek care from for ARI, treatment adherence, and outcome. Methods: cross-sectional was conducted among 100 selected within June December 2012. Study participants were patients or patients' relatives aged >18...

10.2147/ppa.s121800 article EN cc-by-nc Patient Preference and Adherence 2017-03-01

Global influenza-associated acute respiratory infections contribute to 3-5 million severe illnesses requiring hospitalization annually, with 90% of hospitalizations occurring among children < 5 years in developing countries. In Bangladesh, the inadequate availability nationally representative, robust estimates limits allocation resources for prevention and control measures.

10.1111/irv.13352 article EN cc-by Influenza and Other Respiratory Viruses 2024-07-01

Rotavirus vaccines have significantly decreased the burden of diarrheal diseases in countries that introduced them into their immunization programs. In some studies, there has been a small association between rotavirus and intussusception post-marketing surveillance, highlighting importance tracking incidence before after vaccine introduction. The objective this study was to describe epidemiology among Bangladeshi children pre-vaccine We conducted active, hospital-based surveillance for at 7...

10.1016/j.vaccine.2017.08.092 article EN cc-by-nc-nd Vaccine 2017-09-21

Abstract In relapsed and refractory multiple myeloma (RRMM), there are few treatment options once patients progress from the established standard of care. Several bispecific T-cell engagers (TCE) in clinical development for (MM), designed to promote activation tumor killing by binding a receptor target. this study we employ both computational experimental tools investigate how novel trispecific TCE improves activation, proliferation, cytolytic activity T-cells against MM cells. addition CD3...

10.1038/s41598-022-14726-5 article EN cc-by Scientific Reports 2022-06-29
Coming Soon ...